Credit Suisse’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $8.47M | Buy |
|
|||||
|
2023
Q4 | $6.14M | Buy |
|
|||||
|
2023
Q3 | $4.4M | Sell |
|
|||||
|
2023
Q2 | $4.68M | Buy |
|
|||||
|
2023
Q1 | $1.82M | Buy |
|
|||||
|
2022
Q4 | $2.06M | Buy |
|
|||||
|
2022
Q3 | $706K | Buy |
|
|||||
|
2022
Q2 | $520K | Buy |
|
|||||
|
2022
Q1 | $405K | Sell |
|
|||||
|
2021
Q4 | $406K | Buy |
|
|||||
|
2021
Q3 | $337K | Buy |
|
|||||
|
2021
Q2 | $254K | Sell |
|
|||||
|
2021
Q1 | $257K | Sell |
|
|||||
|
2020
Q4 | $895K | Buy |
|